Benjamin Branchu

Papers

2

Total Citations

31

H-Index

2

About

Dr. Benjamin Branchu is a leading figure in urologic oncology, whose research is reshaping the surgical management of kidney cancer. His work centers on the critical comparison of open and robot-assisted partial nephrectomy, with a specific focus on optimizing both clinical outcomes and healthcare economics. Dr. Branchu’s major contribution lies in providing robust, long-term evidence that robotic surgery can match or surpass the oncological efficacy of traditional open techniques, while offering significant advantages in patient recovery. His landmark 2022 study, with 23 citations, analyzed 15 years of data to demonstrate comparable cancer control and complication rates between the two approaches. Building on this, his 2023 cost-effectiveness analysis (8 citations) provided a crucial economic framework, showing that robotic partial nephrectomy is a viable, value-based option for small kidney tumors. By bridging the gap between surgical innovation and fiscal responsibility, Dr. Branchu’s work is instrumental in guiding clinical decision-making and health policy, ensuring that advanced surgical technologies are both effective and accessible.

Research Focus

Key Achievements

2
H-Index
2
Papers
31
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Clinical and oncological outcomes of open partial nephrectomy versus robot assisted partial nephrectomy over 15 years
23 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 8

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago